Delivery Order SPE2DB22D2007-SPE2DB25FH8UT
Award Date
2/5/25
Potential Completion Date
2/27/25
Potential Value
$22K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a specialty medication, with a ceiling value of $1,204.50 and a completion date of December 27, 2024. The contract is a firm-fixed-price, delivery order contract type and was not set aside for a specific business category. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-unit vials of BOTOX with a ceiling value of $8,613.60. The contract is a Firm Fixed Price, non-set-aside award with a period of performance through July 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,564.37 firm fixed price contract is for the delivery of 200 unit vials of BOTOX. The contract has an ultimate completion date of June 26, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-unit vials of the medication BOTOX, with a ceiling value of $4,306.80 and a completion date of June 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 unit vials of BOTOX, a prescription medication, with a ceiling value of $15,056.25. The contract is a firm fixed-price delivery order with a performance period extending through June 26, 2025. This award is associated with Amerisourcebergen Drug Corp's larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 200-unit vials of Botox, a prescription medication, with a ceiling value of $5,128.74 and a performance period through February 12, 2025. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-unit vials of Botox, a specialty medication, with a ceiling value of $2,584.08 and a period of performance through January 2025. The contract is a firm fixed-price, delivery order type with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of 200-unit Botox vials. The $24,788.91 firm fixed-price contract has a completion date of June 17, 2025. The contract is not set aside and provides medical supplies to support federal agencies, including the Defense Health Agency and U.S. Coast Guard. Amerisourcebergen holds a larger $999,999,999.00...
This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 100-unit vials of the medication Botox, with a ceiling value of $1,722.72 and a performance period through July 3, 2025. The contract is designated as a Firm Fixed Price, non-set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of Botox. The contract has a ceiling value of $20,514.96 and a completion date of July 10, 2025. It is a firm-fixed-price contract and is not set aside for any socioeconomic program. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...